Governance Qiagen N.V.

QGEN

NL0015002SN0

Biotechnology & Medical Research

Market Closed - NYSE Other stock markets 04:00:03 2026-07-10 pm EDT			5-day change	1st Jan Change
41.51 ^USD	-1.14%		+3.52%	-12.31%

Jul. 10	Qiagen: Could shareholders finally cash in?
Jul. 10	AlphaValue/Baader Europe Downgrades Qiagen to Add, Lifts PT	MT

Executive Committee: Qiagen N.V.

Manager

Positions heldSince

Thierry Bernard

61 year

Chief Executive Officer

2019-10-06

Roland Sackers

58 year

Director of Finance/CFO

2003-12-31

Daniel Wendorff

Investor Relations Contact

Antonio Santos

Chief Operating Officer

2022-03-31

Lezette Young

Compliance Officer

Stephany Foster

Human Resources Officer

2019-09-30

Composition of the Board of Directors: Qiagen N.V.

Director

CommitteesSince

Stephen Rusckowski

68 year

Compensation Committee	2025-06-25
HR Committee	2025-06-25
Governance Committee Chair	2025-06-25
Nominating Committee Chair	2025-06-25

Elizabeth Tallett

77 year

Audit Committee
Compensation Committee
HR Committee
Governance Committee	2011-05-31
Nominating Committee
Compensation Committee Chair	2010-12-31
Audit Committee Chair	2020-12-31

Mark Stevenson

63 year

Compensation Committee	2022-07-27
Governance Committee	2022-07-27
Nominating Committee	2022-07-27

Eva Pisa

72 year

Compensation Committee Chair	2022-06-22
HR Committee Chair	2022-06-22

Bert van Meurs

65 year

Governance Committee	2024-03-31
Nominating Committee	2024-03-31

Robert McMahon

57 year

Audit Committee Chair

2024-09-08

Toralf Haag

60 year

Audit Committee Chair

2021-01-07

Eva Maria van Pelt

61 year

Audit Committee

2024-02-29

Latest Appointments: Qiagen N.V.

Jul. 10	Qiagen: Could shareholders finally cash in?
May. 12	Qiagen N.V. Announces Metin Colpan Decides Not to Stand for Re-Election of Supervisory Board	CI
Apr. 01	Bruker Corporation Announces Appointment of Thierry L. Bernard to Its Board of Directors, Effective April 1, 2026	CI
Feb. 06	Qiagen: 2025 ended positively, entering 2026 with confidence
Jan. 26	Qiagen appoints Mark Stevenson to supervisory board	RE
Jan. 26	QIAGEN Appoints Mark Stevenson to Supervisory Board	CI
Jan. 26	Qiagen N.V. Announces Supervisory Board Changes, Effective January 23, 2026	CI

More news

Former Officers and Directors: Qiagen N.V.

Insider

Positions held

SinceUntil

Metin Colpan

Director/Board Member	2003-12-31	2026-06-23
Chief Executive Officer	1996-04-28	2002-12-31
Founder	1996-04-28	2026-06-23
Independent Dir/Board Member	2003-12-31	2026-06-23

Ross Levine

Director/Board Member	2015-12-31	2026-01-22
Independent Dir/Board Member	2015-12-31	2026-01-22

Lawrence Rosen

Director/Board Member	2013-06-25	2020-08-20
Chairman	2020-08-20	2025-06-25
Independent Dir/Board Member	2013-06-25	2025-06-25

Elaine Mardis

Director/Board Member	2013-12-31	2025-06-25
Independent Dir/Board Member	2013-12-31	2025-06-25

Nedal Safwat

Corporate Officer/Principal

2021-06-30

2024-11-30

Jonathan Sheldon

Corporate Officer/Principal

2017-12-31

2024-06-30

Phoebe Loh

Public Communications Contact

2019-03-31

2024-03-31

Thomas Neidert

Treasurer

2008-06-30

2023-02-28

Stéphane Bancel

Director/Board Member	2013-06-25	2021-06-28
Independent Dir/Board Member	2013-06-25	2021-06-28

Sundu Brahmasandra

Corporate Officer/Principal

2020-08-31

2021-03-30

Thomas Ebeling

Director/Board Member

2021-02-21

Douglas Liu

Chief Operating Officer

2005-07-11

2020-08-31

Sven Håkan Björklund

Director/Board Member	2017-02-28	2018-05-31
Chairman	2018-05-31	2020-08-20
Independent Dir/Board Member	2017-02-28	2020-08-20

Peer Schatz

Chief Executive Officer	2003-12-31	2019-10-06
Director of Finance/CFO	1992-12-31	2003-12-31

Manuel Méndez Muñiz

Corporate Officer/Principal

2014-09-30

2019-09-30

Barthold Piening

Chief Operating Officer	-	-
Corporate Officer/Principal	2018-11-30	-

Annette Koch

Human Resources Officer

2017-12-31

Laura Furmanski

Private Equity Investor

2014-05-31

2017-11-29

Werner Brandt

Director/Board Member	2010-02-09	-
Chairman	2006-12-31	2016-06-20
Independent Dir/Board Member	2011-08-25	2016-06-20

J. Brown

President

2015-07-31

2016-02-29

James Bradner

Director/Board Member

2015-06-24

2015-12-30

Nils Clausnitzer

President

2010-06-30

2015-11-30

Paula Green

Human Resources Officer

2001-02-28

2015-08-31

Ulrich Schriek

Corporate Officer/Principal

2011-08-25

2015-06-30

Joseph Miller

Comptroller/Controller/Auditor

2005-12-31

2014-12-31

Christian LaPointe

Corporate Officer/Principal

2013-02-28

2014-12-31

Detlev Riesner

Chairman	1998-12-31	2014-06-24
Founder	1996-04-28	2014-06-24
Independent Dir/Board Member	1996-04-28	2014-06-24
Institutional Sales	2011-08-25	2011-08-25

Bernd Peter Uder

Sales & Marketing

2001-02-28

2014-05-31

Robin Meister

Corporate Officer/Principal

2004-12-31

2013-12-31

Erik Hornnaess

Director/Board Member	1997-12-31	2013-06-25
Independent Dir/Board Member	2011-08-25	2013-06-25

Heino von Prondzynski

Director/Board Member	2010-01-04	2013-06-25
Independent Dir/Board Member	2011-08-25	2013-06-25

Tadd Lazarus

Chief Tech/Sci/R&D Officer

2012-12-31

Joachim Schorr

Chief Tech/Sci/R&D Officer	1991-12-31	2011-08-25
Founder	2010-02-09	2010-02-15
Corporate Officer/Principal	2011-08-25	2011-08-25

Vera Kallmeyer

Director/Board Member

2010-12-31

2011-10-20

Thomas S. Clement

Chief Tech/Sci/R&D Officer	2010-12-31	2010-12-31
General Counsel	2010-12-31	2010-12-31

Ellen Sheets

Chief Tech/Sci/R&D Officer

2010-09-08

Dietrich Hauffe

Corporate Officer/Principal

2011-08-30

Gisela Orth

Human Resources Officer

2010-02-10

Sarah Fakih

Public Communications Contact

2018-03-31

Benedikt von Braunmühl

Corporate Officer/Principal

2007-12-31

Franz Wirtz

Director/Board Member

2007-06-19

Heinrich Hornef

Director/Board Member

2007-06-19

Thomas Theuringer

Public Communications Contact

2016-03-31

Jochen Walter

Director/Board Member

2005-12-31

Thomas Schweins

Human Resources Officer	2010-12-31	2016-12-31
Corporate Officer/Principal	2016-12-31	-
Sales & Marketing	2004-12-31	-

Philipp von Hugo

Compliance Officer	2003-11-30	-
General Counsel	2003-11-30	-

Philipp Sixt Lothar von Hugo

General Counsel

2002-12-31

Andreas Horst Düsterhöft

Chief Tech/Sci/R&D Officer

2001-12-31

Manfred Karobath

Director/Board Member	1999-12-31	2015-12-31
Chairman	2016-06-20	-
Independent Dir/Board Member	2011-08-25	-

Michael Collasius

Corporate Officer/Principal

1991-12-31

Victor Shi

Corporate Officer/Principal

Patrick Bruno

Sales & Marketing

Solveigh Mähler

Investor Relations Contact	2011-08-25	-
Public Communications Contact	-	-

Helge Bastian

Sales & Marketing

Victoria von der Decken

Corporate Officer/Principal

2011-08-25

Mohammad El Khoury

President

Martijn Kleijwegt

Director/Board Member

Paul James

Sales & Marketing

Karsten Henco

Founder	-	-
Corporate Officer/Principal	-	-

Garry Merry

Corporate Officer/Principal	-	-
Sales & Marketing	-	1889-12-30

Harald Berninger

Corporate Officer/Principal

Sean P. Scott

Corporate Officer/Principal

Stephen Little

Corporate Officer/Principal

2011-08-31

Peter J. Vozzo

Public Communications Contact

Age distribution of managers

Parity Men Women

Male	12
Female	6

Of which Executive Committee

Male	4
Female	2

Of which Directors

Male	6
Female	2

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Employees

5,500

Sector

Biotechnology & Medical Research

More about the company